Do you want to read an article? Please log in or register.
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation
Atrial Fibrillation
Related content
Atrial FibrillationThrombosis and StrokeTherapy and Intervention
Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation
JAMA Cardiol.
Butt JH, Xian Y, Peterson ED, Olsen PS, Rørth R, Gundlund A, Olesen JB, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL
doi: 10.1001/jamacardio.
Atrial Fibrillation
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
J Am Heart Assoc.
Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z
doi: 10.1161/JAHA.117.007444.
Atrial FibrillationThrombosis and Stroke
Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study
JAMA Cardiol.
Go AS, Reynolds K, Yang J, Gupta N, Lenane J, Sung SH, Harrison TN, Liu TI, Solomon MD
doi: 10.1001/jamacardio.
Atrial Fibrillation
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
J Am Coll Cardiol.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Opatrny J, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY, PRAGUE-17 Trial Investigators.
doi: 10.1016/j.jacc.2020.04.067.
Thrombosis and Stroke
Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation
Stroke.
Flint AC, Conell C, Ren X, Kamel H, Chan SL, Rao VA, Johnston SC
doi: 10.1161/STROKEAHA.
Atrial FibrillationHeart, Artery and Coronary Diseases
The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials
Circulation.
Bennaghmouch N, de Veer AJWM, Bode K, Mahmoodi BK, Dewilde WJM, Lip GYH, Brueckmann M, Kleine E, Ten Berg JM
doi: 10.1161/CIRCULATIONAHA.
Atrial FibrillationTherapy and Intervention
Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation
Circulation.
O'Brien EC, Holmes DN, Thomas LE, Fonarow GC, Allen LA, Gersh BJ, Kowey PR, Singer DE, Ezekowitz MD, Naccarelli GV, Ansell JE, Chan PS, Mahaffey KW, Go AS, Freeman JV, Reiffel JA, Peterson ED, Piccini JP, Hylek EM
doi: 10.1161/CIRCULATIONAHA.
Atrial FibrillationThrombosis and Stroke
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk
Heart.
Verbrugge FH, Martin AC, Siegal D, Pieper K, Illingworth L, Camm AJ, Fox KAA
doi: 10.1136/heartjnl-2019-315873.
COMMENTED
Atrial Fibrillation
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
Am Heart J.
Dalgaard F, North R, Pieper K, Fonarow GC, Kowey PR, Gersh BJ, Mahaffey KW, Pokorney S, Steinberg BA, Naccarrelli G, Allen LA, Reiffel JA, Ezekowitz M, Singer DE, Chan PS, Peterson ED, Piccini JP
doi: 10.1016/j.ahj.2020.01.001.